Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: cancer

How the U.S. Will Set Up New Medicare Drug Price Talks

Ahmed Aboulenein  |  September 6, 2022

WASHINGTON—The U.S. government will soon begin hiring experts and collecting the data needed to launch direct negotiations over prescription drug prices for older and disabled people, a top Biden administration official told Reuters. President Joe Biden last week signed into law the Inflation Reduction Act, introducing new policies to tackle climate change, taxes and the…

Filed under:Drug UpdatesLegislation & Advocacy Tagged with:Centers for Medicare & Medicaid Services (CMS)drug pricingInflation Reduction ActpolicyU.S. Centers for Medicare and Medicaid Services (CMS)

Rheumatologist Reflects on Her Path from Practice to Teaching to Research

Gretchen Henkel  |  September 6, 2022

Anne R. Bass, MD, a professor of medicine at Weill Cornell Medical College/Hospital for Special Surgery, New York, has had a unique career path combining clinical practice with academia. Dr. Bass knew “pretty early” in her academic career that she would be going into medicine. She loved science, but also knew that she wanted to…

Filed under:Career DevelopmentProfessional Topics Tagged with:Dr. Anne R. Bass

Dermatologist, Rheumatologist Discuss Refractory Cutaneous Lupus Case

Richard D. Sontheimer, MD, & Samantha C. Shapiro, MD  |  September 5, 2022

As a dermatologist/internist with a career-long subspecialty interest in the cutaneous manifestations of the rheumatic diseases, I found the case of refractory acute cutaneous lupus by Samantha C. Shapiro, MD, in the June 2022 issue of The Rheumatologist intriguing in several ways, and I felt my perspectives on this case might provide additional educational value…

Filed under:ConditionsOpinionSpeak Out RheumSystemic Lupus Erythematosus Tagged with:case reportcutaneous lupus erythematosus (CLE)Dermatologydiagnostic imagingimage caseimage case reportletter to the editor

Healthy Lifestyle Behaviors Lower Women’s Risk of Developing Rheumatoid Arthritis

Lara C. Pullen, PhD  |  August 25, 2022

Using data from cohorts with detailed lifestyle data and lengthy follow-up, Hahn et al. demonstrated that healthy lifestyle behaviors are associated with a lower risk of developing rheumatoid arthritis (RA), concluding that a substantial proportion of RA may be preventable.

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:Arthritis Care & ResearchbehaviorDietlifestylephysical activityphysical fitnessRheumatoid Arthritis (RA)

A Guiding Light for RA: Insights into Clinical Decision Making, Drug Safety & More

Jason Liebowitz, MD, FACR  |  August 11, 2022

The treatment and management of rheumatoid arthritis (RA) is ever evolving. Here Clifton O. Bingham, MD, discusses the application of RA guidelines, the most recent drug safety information and more.

Filed under:ConditionsMeeting ReportsRheumatoid Arthritis Tagged with:Annual Advances in the Diagnosis & Treatment of the Rheumatic DiseasesDrug SafetyGuidelinesJAK inhibitorsRheumatoid Arthritis (RA)

Just in Case: Understanding Rheumatoid Arthritis Through Patient Cases

Jason Liebowitz, MD, FACR  |  August 11, 2022

Uzma Haque, MD, addressed the management of difficult-to-treat rheumatoid arthritis, using patient case reports to demonstrate clinical decision-making, during a session of the 18th Annual Advances in the Diagnosis & Treatment of the Rheumatic Diseases symposium.

Filed under:ConditionsMeeting ReportsRheumatoid Arthritis Tagged with:Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseasespatient careRheumatoid Arthritis (RA)

JAK Inhibitors: Are All Promises Fulfilled?

Samantha C. Shapiro, MD  |  July 22, 2022

A decade after JAK inhibitors were approved, this EULAR 2022 session looks at whether the drugs have lived up to expectations.

Filed under:Drug UpdatesEULAR/OtherMeeting Reports Tagged with:EULARJAK inhibitorsjakinibsjanus kinase inhibitorRheumatoid Arthritis (RA)

Clinical Guidance & Recommendation Updates for Vasculitis, axSpA & More

Jason Liebowitz, MD, FACR  |  July 15, 2022

In this EULAR 2022 session, new & revised treatment recommendations for ANCA-associated vasculitis, axial spondyloarthritis & rheumatoid arthritis were presented.

Filed under:Axial SpondyloarthritisConditionsEULAR/OtherMeeting ReportsRheumatoid ArthritisVasculitis Tagged with:AAV FocusRheumANCA-Associated Vasculitisanti-neutrophil cytoplasmic antibodies (ANCA)axial spondyloarthritis (SpA)eosinophilic granulomatosis with polyangiitis (EGPA)EULARmicroscopic polyangiitis (MPA)Rheumatoid Arthritis (RA)

Keep ACR’s Advocacy Voice Strong with the American Medical Association

Carina Stanton  |  July 6, 2022

As the result of years of coalition work with partners at the AMA, the ACR recently celebrated a major advocacy win when the FTC announced an investigation of PBM business practices. Join or renew your AMA membership before Sept. 1 so the ACR can keep delegate seats to drive action within the AMA.

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:AdvocacyAMA House of Delegates (HOD)AMA membershipLegislation

ACR-FDA Summit Focuses on Study Design, Safety Considerations

Vanessa Caceres  |  June 21, 2022

Safety considerations and data sources are crucial to consider when designing studies for rheumatology treatments, according to presenters at the 2022 ACR-FDA Summit.

Filed under:Meeting Reports Tagged with:ACR-FDA Summitclinical trialsstudy design

  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 83
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences